Neuromuscular Depolarizing Agents

Known as: Blockers, Depolarizing, Depolarizing Blockers, agents depolarizing 
Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are… (More)

Topic mentions per year

Topic mentions per year

1964-2018
05101519642018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A short-acting depolarizing neuromuscular blocking agent (NMBA), succinylcholine, has been utilized for thyroid operations with… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2006
2006
Malignant hyperthermia (MH) is a dominantly inherited pharmacogenetic condition that manifests as a life-threatening… (More)
Is this relevant?
2001
2001
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disease, triggered by inhalative anesthetics or depolarizing… (More)
Is this relevant?
1999
1999
Malignant hyperthermia (MH) in man is an autosomal dominant disorder of skeletal muscle Ca(2+)-regulation. During anesthesia in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
1997
1997
Malignant hyperthermia is an inherited autosomal disorder of skeletal muscle in which certain volatile anesthetics and… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1997
1997
Malignant hyperthermia (MH) is an autosomal dominant disorder which is potentially lethal in susceptible individuals on exposure… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1995
1995
The frequency of postoperative residual neuromuscular block following the use of the long-acting non-depolarizing muscle… (More)
Is this relevant?
1995
1995
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disease for which MH susceptibility (MHS) is transmitted as… (More)
  • figure I
  • table I
  • table 2
  • figure 2
  • table 3
Is this relevant?
1994
1994
Malignant hyperthermia (MH) is a potentially fatal autosomal dominant disorder of skeletal muscle and is triggered in susceptible… (More)
Is this relevant?
1991
1991
The pharmacodynamics and pharmacokinetics of a new non-depolarizing neuromuscular blocking agent, Org 9426, were investigated… (More)
Is this relevant?